Diabetic Product XigaMet Loses to ZitaMet Under Heightened Pharma Trademark Scrutiny
The Bombay High Court has restrained Gleck Pharma from using XIGAMET for its diabetes product, finding it deceptively similar to Glenmark’s ZITA-MET. This decision highlights the Court’s heightened…